Navigation Links
Essilor's 2007 Third-Quarter Report
Date:10/23/2007

CHARENTON-LE-PONT, France, October 24 /PRNewswire-FirstCall/ -- - Financial Information for the First Nine Months of 2007

- Continued Strong Organic Growth, With Revenue Up 8.5% Like-for-Like

Essilor International, the world leader in ophthalmic optics, today announced its consolidated revenue for the nine months ended September 30, 2007.

Consolidated revenue for the first nine months

EUR millions 2007 (9 2006 (9 % change Like-for-like

months) months) change*

Consolidated revenue 2,200.1 2,022.6 8.8% 8.5%

Europe 987.0 895.3 10.2% 7.4%

North America 932.4 882.9 5.6% 8.3%

Asia-Pacific 200.9 175.9 14.2% 12.8%

Latin America 79.8 68.5 16.5% 15.3%

(*)Based on a comparable scope of consolidation and at constant exchange rates.

Consolidated revenue for the first nine months of 2007 totaled EUR2.2 billion, representing an increase of 8.8% on a reported basis and 8.5% like-for-like. Changes in scope of consolidation accounted for 3.8% of growth, corresponding mainly to acquisitions made since the beginning of the year and, to a lesser extent, to businesses acquired in 2006. The currency effect was a negative 3.6%.

Like-for-like growth matched the first-half 2007 rate of 8.5%, once again significantly exceeding the Company's trend rate. This performance was attributable to:

- Around 5% growth in lens sales volume in the first nine months, outperforming the market.

- The roughly 3.5% impact of favorable changes in the price mix.

Essilor is enjoying strong demand for new generation lenses offering new materials, optical designs or coatings. Sales of medium and high-index lenses and photochromic lenses are particularly robust. In all, value-added lenses now a
'/>"/>

SOURCE Essilor
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Third Wave Reports Third-Quarter Financial Results
2. GE Healthcare third-quarter profits up 17 percent
3. Midwest small-cap life sciences turn in mixed third-quarter results
4. Assess the In Vivo Activation of Signal Transduction Pathways with PathDetect Reporting Systems
5. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
6. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
7. Stable HeLa Luciferase Reporter Cell Lines Expressing GAL4 Fusion Transactivators
8. Versatile Reporter Vectors for Monitoring Viral Transduction
9. In Vivo Signal Transduction Pathway Reporting Systems
10. Improved Vectors for PathDetect Trans-Reporting Systems
11. New Reporter Plasmids for Studying Interferon-Stimulated Signal Transduction Pathways
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Outside GC, the leading provider of ... of Debbie Casey as a member of the firm, ... , Debbie has spent over 20 years ... Medical Care North America in both legal and business ... work with Outside GC’s growing list of healthcare clients, ...
(Date:2/27/2015)... and SUMMERLAND, British Columbia , ... XON ), a leader in synthetic biology, ... acquire  Okanagan Specialty Fruits (OSF), the pioneering agricultural ... the world,s first non-browning apple. Through the acquisition, Intrexon ... that is more appetizing and convenient for consumers while ...
(Date:2/27/2015)... 2015 Immunovaccine Inc. (“Immunovaccine”) (TSX: ... today announced that the U.S. Food and Drug ... designation and Phase I clinical trials of the ... mutual co-development agreement signed with Gilead Life Sciences. ... for the DPX-Survivac. , “We have been in ...
(Date:2/27/2015)... 27, 2015 FamilyFarms Group is pleased ... of State Line Farms, received the 2015 Tomorrow’s Top ... under the age of 35, who has demonstrated excellence ... honor to win the Tomorrow's Top Producer Horizon Award. ... the Top Producer Award and learning from their experiences. ...
Breaking Biology Technology:Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
... Feb. 4 Patients with frequently,relapsing bipolar disorder ... an,initial relapse when risperidone long-acting injection (RLAI) was ... The study compared,patients who received RLAI and standard ... placebo., The study was presented yesterday at ...
... 4 Ardea Biosciences,Inc. (Nasdaq: RDEA ) today ... Advisory Board (SAB) with the,appointment of seven members, chaired ... scientific advice and counsel to the Company regarding,key decisions ... "Establishing a strong scientific advisory board for our ...
... 4 Uroplasty, Inc. (Amex:,UPI) announced today that ... of fiscal 2008 ended December 31, 2007, before ... Company will host a conference call to,discuss these ... a.m. Central,Time. David Kaysen, President and Chief Executive ...
Cached Biology Technology:Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 2Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 3Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 4Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 5Ardea Biosciences Establishes Scientific Advisory Board for HIV Program 2Ardea Biosciences Establishes Scientific Advisory Board for HIV Program 3Ardea Biosciences Establishes Scientific Advisory Board for HIV Program 4
(Date:2/24/2015)... , Feb. 24, 2015 This report analyzes the worldwide ... following Segments: Face Biometrics, and Voice Biometrics. The report provides separate ... Japan , Europe , ... Africa , and Latin America . ... 2020. Also, a seven-year historic analysis is provided for these markets. ...
(Date:2/19/2015)... 2015 Research and Markets ( ... "Military Electro-Optical / Infrared Systems Market by ... - Forecast to 2020" report to their ... market is expected to reach $16.35 billion by ... This report segments the military electro-optical/infrared systems ...
(Date:2/12/2015)... MINNETONKA, Minn. , Feb. 12, 2015 /PRNewswire/ ... technology company specializing in clinical study management systems, ... Partner Program , further distinguishing iMedNet ... for Clinical Research Organizations (CROs) and healthcare consultants.  ... sales support, prospective customer referrals and numerous co-marketing ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... in some living animal groups today has taken on ... evidence shows the feature is at least 100 million ... Munich (Germany), has led an international team of scientists, ... Their research has revealed fossilised evidence for reproduction using ...
... at Oregon State University recently completed the largest animal study ... challenge some basic concepts about how to determine what level ... study found that acceptable levels of at least one carcinogen ... believed. It also indicates that for many purposes trout may ...
... Conservation Society (WCS) announced today a major breakthrough in the ... According to the study, researchers will be able to ... from the unique DNA signature found in their dung. ... samples from tigers that were darted and sedated. The ...
Cached Biology News:Size did matter 2Improved method developed to test carcinogen risk 2Improved method developed to test carcinogen risk 3The straight poop on counting tigers 2
... Maximize the value of your microarray ... offer the support you need from ... the most up to date methods. ... the Gene Expression Profiling Service or ...
Formula variant: With macro- and micronutrients. Physical Form: powder Suitab tst: plant cell culture tested...
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap, packed in double bag. (20/ca) Packaging: ...
... The Yeast Protein Kit is a simple ... of yeast cells. The kit has been optimized ... but can be used for any fungus species ... The Zymolyase digestion procedure effectively generates spheroplasts of ...
Biology Products: